Early phase dynamics of traceable mCherry fluorescent protein-carrying HIV-1 infection in human peripheral blood mononuclear cells-transplanted NOD/SCID/Jak3 -/- mice

Alford, 2009, Molecular probes for the in vivo imaging of cancer, Mol. Biosyst., 5, 1279, 10.1039/b911307j Anderson, 2014, Modeling mucosal cell-associated HIV type 1 transmission in vitro, J. Infect. Dis., 210, S648, 10.1093/infdis/jiu537 Aoki, 2012, Loss of the protease dimerization inhibition activity of tipranavir (TPV) and its association with the acquisition of resistance to TPV by HIV-1, J. Virol., 86, 13384, 10.1128/JVI.07234-11 Asmal, 2016, Pathogenic infection of Rhesus macaques by an evolving SIV-HIV derived from CCR5-using envelope genes of acute HIV-1 infections, Virology, 499, 298, 10.1016/j.virol.2016.09.021 Bomsel, 1997, Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier, Nat. Med., 3, 42, 10.1038/nm0197-42 CDC Fact Sheet, 2016 Chen, 2007, Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses, J. Virol., 81, 12582, 10.1128/JVI.00381-07 Chihara, 2010, IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation, Cell Death Differ., 17, 1917, 10.1038/cdd.2010.60 Chihara, 2012, HIV-1 proteins preferentially activate anti-inflammatory M2-type macrophages, J. Immunol., 188, 3620, 10.4049/jimmunol.1101593 Denton, 2010, Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice, PloS One, 5, e8829, 10.1371/journal.pone.0008829 Edmonds, 2011, The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study, PLoS Med., 8, e1001044, 10.1371/journal.pmed.1001044 Fang, 1999, PCR-mediated recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA, Nat. Med., 5, 239, 10.1038/5607 Grobler, 2016 Haase, 2010, Targeting early infection to prevent HIV-1 mucosal transmission, Nature, 464, 217, 10.1038/nature08757 Hattori, 2009, Antimicrob. Agents Chemother., 53, 3887, 10.1128/AAC.00270-09 Irvine, 2015, Efficacy of HIV postexposure prophylaxis: systematic review and meta-analysis of nonhuman primate studies, Clin. Infect. Dis., 60, S165, 10.1093/cid/civ069 Koh, 2007, Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization, J. Biol. Chem., 282, 28709, 10.1074/jbc.M703938200 Kosaka, 2009, Clinical implications of near-infrared fluorescence imaging in cancer, Future Oncol., 5, 1501, 10.2217/fon.09.109 Lohse, 2007, Improved survival in HIV-infected persons: consequences and perspectives, J. Antimicrob. Chemother., 60, 461, 10.1093/jac/dkm241 Louissaint, 2012, Distribution of cell-free and cell-associated HIV surrogates in the female genital tract after simulated vaginal intercourse, J. Infect. Dis., 205, 725, 10.1093/infdis/jir841 Mazurov, 2010, Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors, PLoS Pathog., 6, e1000788, 10.1371/journal.ppat.1000788 Miyawaki, 2003, Lighting up cells: labelling proteins with fluorophores, Nat. Cell Biol. Suppl., S1 Moench, 2014, Cell-associated transmission of HIV type 1 and other lentiviruses in small-animal models, J. Infect. Dis., 210, S654, 10.1093/infdis/jiu368 Nakata, 2005, Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model, J. Virol., 79, 2087, 10.1128/JVI.79.4.2087-2096.2005 Nakata, 2007, Activity against human immunodeficiency virus type 1, intracellular metabolism, and effects on human DNA polymerases of 4'-ethynyl-2-fluoro-2'-deoxyadenosine, Antimicrob. Agents Chemother., 51, 2701, 10.1128/AAC.00277-07 Nischang, 2012, Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1, PloS One, 7, e38853, 10.1371/journal.pone.0038853 Okada, 2008, Early development of human hematopoietic and acquired immune systems in new born NOD/Scid/Jak3null mice intrahepatic engrafted with cord blood-derived CD34 + cells, Int. J. Hematol., 88, 476, 10.1007/s12185-008-0215-z Pope, 2003, Transmission, acute HIV-1 infection and the quest for strategies to prevent infection, Nat. Med., 9, 847, 10.1038/nm0703-847 Pudney, 1992, Pre-ejaculatory fluid as potential vector for sexual transmission of HIV-1, Lancet, 340, 1470, 10.1016/0140-6736(92)92659-4 Riddick, 2016, Simian immunodeficiency virus SIVagm efficiently utilizes non-CCR5 entry pathways in African green monkey lymphocytes: potential role for GPR15 and CXCR6 as viral coreceptors, J. Virol., 90, 2316, 10.1128/JVI.02529-15 Salle, 2010, Infection of macaques after vaginal exposure to cell-associated simian immunodeficiency virus, J. Infect. Dis., 202, 337, 10.1086/653619 Santangelo, 2015, Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques, Nat. methods, 12, 427, 10.1038/nmeth.3320 Stoddart, 2015, Oral administration of the nucleoside EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaque, Antimicrob. Agents. Chemother., 59, 4190, 10.1128/AAC.05036-14 Sun, 2007, Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1, J. Exp. Med., 204, 705, 10.1084/jem.20062411 Tilney, 1971, Patterns of lymphatic drainage in the adult laboratory rat, J. Anat., 109, 369 Tsai, 1995, Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine, Science, 270, 1197, 10.1126/science.270.5239.1197 Tsai, 1998, Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment, J. Virol., 72, 4265, 10.1128/JVI.72.5.4265-4273.1998 UNAIDS report on the global epidemic 2013. http://www.unaids.org/en/resources/campaigns/globalreport2013/globalreport. Van Duyne, 2009, The utilization of humanized mouse models for the study of human retroviral infections, Retrovirology, 6, 76, 10.1186/1742-4690-6-76 Zhu, 2001, Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes, J. Virol., 75, 3791, 10.1128/JVI.75.8.3791-3801.2001